Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)
26 Novembre 2024 - 6:43PM
Edgar (US Regulatory)
Schedule of Investments (unaudited)
September 30, 2024
BlackRock Enhanced Global Dividend Trust (BOE)
(Percentages shown are based on Net Assets)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Novo Nordisk A/S, Class B
|
|
|
|
|
|
|
|
|
|
|
|
LVMH Moet Hennessy Louis Vuitton SE
|
|
|
|
|
|
|
|
|
|
|
|
Bank Rakyat Indonesia Persero Tbk PT
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Banco Bilbao Vizcaya Argentaria SA
|
|
|
|
|
|
|
Zurich Insurance Group AG, Class N
|
|
|
|
|
|
|
Taiwan Semiconductor Manufacturing Co. Ltd.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AceVector Limited, Series I, (Acquired 08/31/18, Cost:
$2,637,143)(a)(b)(c)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Baker Hughes Co., Class A(d)
|
|
|
|
|
|
|
|
|
Citizens Financial Group, Inc.(d)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Intercontinental Exchange, Inc.(e)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States (continued)
|
|
Mastercard, Inc., Class A
|
|
|
|
Meta Platforms, Inc., Class A
|
|
|
|
|
|
|
|
|
Mondelez International, Inc., Class A(e)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Philip Morris International, Inc.(d)(e)
|
|
|
|
Republic Services, Inc.(d)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Texas Instruments, Inc.(d)
|
|
|
|
|
|
|
|
|
UnitedHealth Group, Inc.(d)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Long-Term Investments — 101.2%
(Cost: $575,383,403)
|
|
|
|
Money Market Funds — 0.1%
|
|
BlackRock Liquidity Funds, T-Fund, Institutional Shares,
4.83%(f)(g)
|
|
|
|
Total Short-Term Securities — 0.1%
(Cost: $999,790)
|
|
Total Investments Before Options Written — 101.3%
(Cost: $576,383,193)
|
|
Options Written — (1.4)%
(Premiums Received: $(7,837,448))
|
|
Total Investments, Net of Options Written — 99.9%
(Cost: $568,545,745)
|
|
Other Assets Less Liabilities — 0.1%
|
|
|
|
|
|
|
Security is valued using significant unobservable inputs and is classified as Level
3 in the
fair value hierarchy.
|
|
|
Non-income producing security.
|
|
|
Restricted security as to resale, excluding 144A securities. The Trust held restricted
securities with a current value of $248,793, representing less than 0.05% of its net
assets
as of period end, and an original cost of $2,637,143.
|
|
|
All or a portion of the security has been pledged as collateral in connection with
outstanding OTC derivatives.
|
|
|
All or a portion of the security has been pledged and/or segregated as collateral
in
connection with outstanding exchange-traded options written.
|
|
|
|
|
|
Annualized 7-day yield as of period end.
|
Schedule of Investments
1
Schedule of Investments (unaudited)(continued)
September 30, 2024
BlackRock Enhanced Global Dividend Trust (BOE)
Affiliates
Investments in issuers considered to be affiliate(s) of the Trust during the period
ended September 30, 2024 for purposes of Section 2(a)(3) of the Investment Company
Act of 1940, as amended, were as follows:
|
|
|
|
|
|
Change in
Unrealized
Appreciation
(Depreciation)
|
|
|
|
Capital Gain
Distributions
from
Underlying
Funds
|
BlackRock Cash Funds: Institutional, SL Agency Shares(a)
|
|
|
|
|
|
|
|
|
|
BlackRock Liquidity Funds, T-Fund, Institutional Shares
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of period end, the entity is no longer held.
|
|
|
Represents net amount purchased (sold).
|
|
|
All or a portion represents securities lending income earned from the reinvestment
of cash collateral from loaned securities, net of fees and collateral investment expenses,
and other
payments to and from borrowers of securities.
|
Derivative Financial Instruments Outstanding as of Period End
Exchange-Traded Options Written
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Intercontinental Exchange, Inc.
|
|
|
|
|
|
|
|
Mastercard, Inc., Class A
|
|
|
|
|
|
|
|
Meta Platforms, Inc., Class A
|
|
|
|
|
|
|
|
Philip Morris International, Inc.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Meta Platforms, Inc., Class A
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Baker Hughes Co., Class A
|
|
|
|
|
|
|
|
Baker Hughes Co., Class A
|
|
|
|
|
|
|
|
Citizens Financial Group, Inc.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Intercontinental Exchange, Inc.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mastercard, Inc., Class A
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Schedule of Investments (unaudited)(continued)
September 30, 2024
BlackRock Enhanced Global Dividend Trust (BOE)
Exchange-Traded Options Written (continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mastercard, Inc., Class A
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mondelez International, Inc., Class A
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Baker Hughes Co., Class A
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Meta Platforms, Inc., Class A
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mondelez International, Inc., Class A
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Philip Morris International, Inc.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mastercard, Inc., Class A
|
|
|
|
|
|
|
|
Mondelez International, Inc., Class A
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Baker Hughes Co., Class A
|
|
|
|
|
|
|
|
Citizens Financial Group, Inc.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Morgan Stanley & Co. International PLC
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Goldman Sachs International
|
|
|
|
|
|
|
|
|
|
Morgan Stanley & Co. International PLC
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Goldman Sachs International
|
|
|
|
|
|
|
|
Novo Nordisk A/S, Class B
|
Goldman Sachs International
|
|
|
|
|
|
|
|
Schedule of Investments
3
Schedule of Investments (unaudited)(continued)
September 30, 2024
BlackRock Enhanced Global Dividend Trust (BOE)
OTC Options Written (continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Goldman Sachs International
|
|
|
|
|
|
|
|
Banco Bilbao Vizcaya Argentaria SA
|
Morgan Stanley & Co. International PLC
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Morgan Stanley & Co. International PLC
|
|
|
|
|
|
|
|
|
|
Goldman Sachs International
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Zurich Insurance Group AG, Class N
|
Goldman Sachs International
|
|
|
|
|
|
|
|
LVMH Moet Hennessy Louis Vuitton SE
|
Goldman Sachs International
|
|
|
|
|
|
|
|
Novo Nordisk A/S, Class B
|
Goldman Sachs International
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Morgan Stanley & Co. International PLC
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Novo Nordisk A/S, Class B
|
|
|
|
|
|
|
|
|
Banco Bilbao Vizcaya Argentaria SA
|
Morgan Stanley & Co. International PLC
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LVMH Moet Hennessy Louis Vuitton SE
|
Morgan Stanley & Co. International PLC
|
|
|
|
|
|
|
|
Novo Nordisk A/S, Class B
|
|
|
|
|
|
|
|
|
|
|
Morgan Stanley & Co. International PLC
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Taiwan Semiconductor Manufacturing Co. Ltd.
|
Goldman Sachs International
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Goldman Sachs International
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Goldman Sachs International
|
|
|
|
|
|
|
|
Taiwan Semiconductor Manufacturing Co. Ltd.
|
|
|
|
|
|
|
|
|
|
|
Goldman Sachs International
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Value Hierarchy as of Period End
Various inputs are used in determining the fair value of financial instruments at
the measurement date. These inputs to valuation techniques are categorized into a
fair value hierarchy consisting of three broad levels for financial reporting purposes as follows:
• Level 1 – Unadjusted price quotations in active markets/exchanges that the Trust has the ability to access for identical, unrestricted assets or liabilities;
• Level 2 – Inputs other than quoted prices included within level 1 that are observable for the asset or liability, either directly or indirectly; and
• Level 3 – Inputs that are unobservable and significant to the entire fair value measurement for the asset or liability (including the Valuation Committee’s assumptions used in determining the fair value of financial instruments).
The hierarchy gives the highest priority to unadjusted quoted prices in active markets
for identical assets or liabilities (Level 1 measurements) and the lowest priority
to unobservable inputs (Level 3 measurements). Accordingly, the degree of judgment exercised
in determining fair value is greatest for instruments categorized in Level 3. The
inputs used to measure fair value may fall into different levels of the fair value
hierarchy. In such cases, for disclosure purposes, the fair value hierarchy classification
is determined based on the lowest level input that is significant to the fair value measurement
in its entirety. Investments classified within Level 3 have significant unobservable
inputs used by the Valuation Committee in determining the price for Fair Valued Investments.
Level 3 investments include equity or debt issued by privately held companies or funds. There may not be a secondary market, and/or there are a limited number of investors.
The categorization of a value determined for financial instruments is based on the
pricing transparency of the financial instruments and is not necessarily an indication of the risks associated with investing in those securities. For information about the Trust’s policy regarding valuation of financial instruments, refer to its most recent financial
statements.
Schedule of Investments (unaudited)(continued)
September 30, 2024
BlackRock Enhanced Global Dividend Trust (BOE)
Fair Value Hierarchy as of Period End (continued)
The following table summarizes the Trust’s financial instruments categorized in the fair value hierarchy. The breakdown of the Trust’s financial instruments into major categories is disclosed in the Schedule of Investments above.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative Financial Instruments(a)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative financial instruments are options written. Options written are shown at
value.
|
Schedule of Investments
5
Grafico Azioni BlackRock Enhanced Globa... (NYSE:BOE)
Storico
Da Ott 2024 a Nov 2024
Grafico Azioni BlackRock Enhanced Globa... (NYSE:BOE)
Storico
Da Nov 2023 a Nov 2024
